{"position": "Radiochemistry Research Assistant", "company": "Stanford University", "profiles": ["Summary Research professional with experience in medicinal chemistry, radiochemistry, pre-clinical/clinical PET imaging, and molecular biology. Currently working in biotech start-up EpiBiome, a bacteriophage company, located in the Johnson & Johnson Innovation Lab in South San Francisco. My goal within the company is to further develop my scientific skill set in a dynamic and fast paced environment that will enable and encourage professional growth in business management, external affairs and product development. \n \nwww.epibiome.com Summary Research professional with experience in medicinal chemistry, radiochemistry, pre-clinical/clinical PET imaging, and molecular biology. Currently working in biotech start-up EpiBiome, a bacteriophage company, located in the Johnson & Johnson Innovation Lab in South San Francisco. My goal within the company is to further develop my scientific skill set in a dynamic and fast paced environment that will enable and encourage professional growth in business management, external affairs and product development. \n \nwww.epibiome.com Research professional with experience in medicinal chemistry, radiochemistry, pre-clinical/clinical PET imaging, and molecular biology. Currently working in biotech start-up EpiBiome, a bacteriophage company, located in the Johnson & Johnson Innovation Lab in South San Francisco. My goal within the company is to further develop my scientific skill set in a dynamic and fast paced environment that will enable and encourage professional growth in business management, external affairs and product development. \n \nwww.epibiome.com Research professional with experience in medicinal chemistry, radiochemistry, pre-clinical/clinical PET imaging, and molecular biology. Currently working in biotech start-up EpiBiome, a bacteriophage company, located in the Johnson & Johnson Innovation Lab in South San Francisco. My goal within the company is to further develop my scientific skill set in a dynamic and fast paced environment that will enable and encourage professional growth in business management, external affairs and product development. \n \nwww.epibiome.com Experience Scientist, Molecular Biologist EpiBiome November 2014  \u2013 Present (10 months) San Francisco, California Molecular biology: Bacterial DNA extraction from a variety of sample types, quantification, PCR, gel electrophoresis, library preparation, next-generation sequencing on Illumina MiSeq, shotgun metagenomics, whole genome sequencing, 16S amplicon sequencing. \nManufacturing & Operations \nResearch & Development \n \n Radiochemistry Research Assistant Stanford University Medical Center May 2012  \u2013  November 2014  (2 years 7 months) Standford University Medical Center, Cyclotron and Radiochemistry Facility Synthesis of F-18, C-11, Cu-64 and Ga-68 labeled radiopharmaceuticals for clinic and research Performing relevant QA/QC \nOperation of the cyclotron (GE PETtrace) \nClinical translation of tracers \nLab management and administrative functions - setting up the new clinical GMP lab, working with facilities staff and outside product vendors, organizing cyclotron schedule, performing maintenance of equipment. \nTraining new staff \nTrouble-shooting issues with chemistry or technical equipment \nWritings SOPs, generating INDs for new clinical tracers, reviewing/editing journal articles. Master's Student in Radiochemistry/PET Biotesting University of Ottawa Heart Institute September 2009  \u2013  April 2012  (2 years 8 months) Ottawa, Ontario Design and synthesis of novel F-18 labeled AT1 receptor PET tracer, including cold synthesis, translation to hot chemistry in an automated module (FX N Pro), metabolite analysis (by column switch HPLC) and microPET imaging (Siemens microPET) in normal rats to generate SUV/TAC. Submission Screening Officer Health Canada May 2008  \u2013  August 2008  (4 months) Ottawa, Canada Co-op Position. Screened incoming notifications and amendments to Clinical Trials Applications (CTA). Also took on a secondary role with the Special Access Programme (SAP) where I screened requests for drugs not approved for sale in Canada. Medicinal Chemistry Researcher MethylGene Inc. January 2007  \u2013  August 2007  (8 months) Co-op Position Scientist, Molecular Biologist EpiBiome November 2014  \u2013 Present (10 months) San Francisco, California Molecular biology: Bacterial DNA extraction from a variety of sample types, quantification, PCR, gel electrophoresis, library preparation, next-generation sequencing on Illumina MiSeq, shotgun metagenomics, whole genome sequencing, 16S amplicon sequencing. \nManufacturing & Operations \nResearch & Development \n \n Scientist, Molecular Biologist EpiBiome November 2014  \u2013 Present (10 months) San Francisco, California Molecular biology: Bacterial DNA extraction from a variety of sample types, quantification, PCR, gel electrophoresis, library preparation, next-generation sequencing on Illumina MiSeq, shotgun metagenomics, whole genome sequencing, 16S amplicon sequencing. \nManufacturing & Operations \nResearch & Development \n \n Radiochemistry Research Assistant Stanford University Medical Center May 2012  \u2013  November 2014  (2 years 7 months) Standford University Medical Center, Cyclotron and Radiochemistry Facility Synthesis of F-18, C-11, Cu-64 and Ga-68 labeled radiopharmaceuticals for clinic and research Performing relevant QA/QC \nOperation of the cyclotron (GE PETtrace) \nClinical translation of tracers \nLab management and administrative functions - setting up the new clinical GMP lab, working with facilities staff and outside product vendors, organizing cyclotron schedule, performing maintenance of equipment. \nTraining new staff \nTrouble-shooting issues with chemistry or technical equipment \nWritings SOPs, generating INDs for new clinical tracers, reviewing/editing journal articles. Radiochemistry Research Assistant Stanford University Medical Center May 2012  \u2013  November 2014  (2 years 7 months) Standford University Medical Center, Cyclotron and Radiochemistry Facility Synthesis of F-18, C-11, Cu-64 and Ga-68 labeled radiopharmaceuticals for clinic and research Performing relevant QA/QC \nOperation of the cyclotron (GE PETtrace) \nClinical translation of tracers \nLab management and administrative functions - setting up the new clinical GMP lab, working with facilities staff and outside product vendors, organizing cyclotron schedule, performing maintenance of equipment. \nTraining new staff \nTrouble-shooting issues with chemistry or technical equipment \nWritings SOPs, generating INDs for new clinical tracers, reviewing/editing journal articles. Master's Student in Radiochemistry/PET Biotesting University of Ottawa Heart Institute September 2009  \u2013  April 2012  (2 years 8 months) Ottawa, Ontario Design and synthesis of novel F-18 labeled AT1 receptor PET tracer, including cold synthesis, translation to hot chemistry in an automated module (FX N Pro), metabolite analysis (by column switch HPLC) and microPET imaging (Siemens microPET) in normal rats to generate SUV/TAC. Master's Student in Radiochemistry/PET Biotesting University of Ottawa Heart Institute September 2009  \u2013  April 2012  (2 years 8 months) Ottawa, Ontario Design and synthesis of novel F-18 labeled AT1 receptor PET tracer, including cold synthesis, translation to hot chemistry in an automated module (FX N Pro), metabolite analysis (by column switch HPLC) and microPET imaging (Siemens microPET) in normal rats to generate SUV/TAC. Submission Screening Officer Health Canada May 2008  \u2013  August 2008  (4 months) Ottawa, Canada Co-op Position. Screened incoming notifications and amendments to Clinical Trials Applications (CTA). Also took on a secondary role with the Special Access Programme (SAP) where I screened requests for drugs not approved for sale in Canada. Submission Screening Officer Health Canada May 2008  \u2013  August 2008  (4 months) Ottawa, Canada Co-op Position. Screened incoming notifications and amendments to Clinical Trials Applications (CTA). Also took on a secondary role with the Special Access Programme (SAP) where I screened requests for drugs not approved for sale in Canada. Medicinal Chemistry Researcher MethylGene Inc. January 2007  \u2013  August 2007  (8 months) Co-op Position Medicinal Chemistry Researcher MethylGene Inc. January 2007  \u2013  August 2007  (8 months) Co-op Position Languages French French French Skills Medicinal Chemistry Radiochemistry Organic Chemistry Time Management Molecular Imaging Pharmacology GMP Molecular Biology Clinical Trials Biochemistry Clinical Research Clinical Development Positron Emission... Organic Synthesis Pharmacovigilance Scientific Writing Organization CMC Regulatory Affairs Regulatory Affairs PET imaging Early-stage Startups Biotechnology See 7+ \u00a0 \u00a0 See less Skills  Medicinal Chemistry Radiochemistry Organic Chemistry Time Management Molecular Imaging Pharmacology GMP Molecular Biology Clinical Trials Biochemistry Clinical Research Clinical Development Positron Emission... Organic Synthesis Pharmacovigilance Scientific Writing Organization CMC Regulatory Affairs Regulatory Affairs PET imaging Early-stage Startups Biotechnology See 7+ \u00a0 \u00a0 See less Medicinal Chemistry Radiochemistry Organic Chemistry Time Management Molecular Imaging Pharmacology GMP Molecular Biology Clinical Trials Biochemistry Clinical Research Clinical Development Positron Emission... Organic Synthesis Pharmacovigilance Scientific Writing Organization CMC Regulatory Affairs Regulatory Affairs PET imaging Early-stage Startups Biotechnology See 7+ \u00a0 \u00a0 See less Medicinal Chemistry Radiochemistry Organic Chemistry Time Management Molecular Imaging Pharmacology GMP Molecular Biology Clinical Trials Biochemistry Clinical Research Clinical Development Positron Emission... Organic Synthesis Pharmacovigilance Scientific Writing Organization CMC Regulatory Affairs Regulatory Affairs PET imaging Early-stage Startups Biotechnology See 7+ \u00a0 \u00a0 See less Education University of Ottawa / Universit\u00e9 d'Ottawa M.Sc.,  Radiochemistry/PET Bio-testing 2009  \u2013 2011 University of Ottawa / Universit\u00e9 d'Ottawa B.Sc,  Biopharmaceutical Sciences (honors) , specialization in Medicinal Chemistry, with Co-op , Magna cum laude 2004  \u2013 2009 University of Ottawa / Universit\u00e9 d'Ottawa M.Sc.,  Radiochemistry/PET Bio-testing 2009  \u2013 2011 University of Ottawa / Universit\u00e9 d'Ottawa M.Sc.,  Radiochemistry/PET Bio-testing 2009  \u2013 2011 University of Ottawa / Universit\u00e9 d'Ottawa M.Sc.,  Radiochemistry/PET Bio-testing 2009  \u2013 2011 University of Ottawa / Universit\u00e9 d'Ottawa B.Sc,  Biopharmaceutical Sciences (honors) , specialization in Medicinal Chemistry, with Co-op , Magna cum laude 2004  \u2013 2009 University of Ottawa / Universit\u00e9 d'Ottawa B.Sc,  Biopharmaceutical Sciences (honors) , specialization in Medicinal Chemistry, with Co-op , Magna cum laude 2004  \u2013 2009 University of Ottawa / Universit\u00e9 d'Ottawa B.Sc,  Biopharmaceutical Sciences (honors) , specialization in Medicinal Chemistry, with Co-op , Magna cum laude 2004  \u2013 2009 ", "Summary I am an analytical chemist with vast experience of supporting phase ll drug development.  \nBesides the regular activities of drug product support (dissolution, assay, stability etc...), I also developed chromatography methods for active pharmaceutical ingredients and their intermediates and for detection of genotoxic impurities. I am experienced in RP-LC, chiral-LC/SFC, HILIC, and GC-FID method development. Summary I am an analytical chemist with vast experience of supporting phase ll drug development.  \nBesides the regular activities of drug product support (dissolution, assay, stability etc...), I also developed chromatography methods for active pharmaceutical ingredients and their intermediates and for detection of genotoxic impurities. I am experienced in RP-LC, chiral-LC/SFC, HILIC, and GC-FID method development. I am an analytical chemist with vast experience of supporting phase ll drug development.  \nBesides the regular activities of drug product support (dissolution, assay, stability etc...), I also developed chromatography methods for active pharmaceutical ingredients and their intermediates and for detection of genotoxic impurities. I am experienced in RP-LC, chiral-LC/SFC, HILIC, and GC-FID method development. I am an analytical chemist with vast experience of supporting phase ll drug development.  \nBesides the regular activities of drug product support (dissolution, assay, stability etc...), I also developed chromatography methods for active pharmaceutical ingredients and their intermediates and for detection of genotoxic impurities. I am experienced in RP-LC, chiral-LC/SFC, HILIC, and GC-FID method development. Experience Senior Research Associate II Gilead Sciences February 2015  \u2013 Present (7 months) Foster City Phase III support for combo drug product. Analytical Chemistry Research Associate Genentech June 2012  \u2013  February 2015  (2 years 9 months) South San Francisco Phase ll support for drug product (DP) and active pharmaceutical ingredients (API) development. HPLC/ UPLC method development for late stage research projects. Ion chromatography with IC systems and with HPLC (based on HILIC and CAD detection). Dissolution / disintegration tests, content and blend uniformity. HSGC with FID and EI-MS detection. H-1/C-13 NMR. Particle size analysis and more. Radiochemistry Research Assistant Stanford University Medical Center January 2011  \u2013  June 2012  (1 year 6 months) Production of imaging probes for proliferation, angiogenesis and metabolism. \nReviewing and editing of SOP's, master batch recordes and QC forms. Organic Chemistry Hadassah medical center August 2008  \u2013  August 2010  (2 years 1 month) Independent research and development of click chemistry probe for peptide and small molecules labeling Radiochemistry Hadassah August 2008  \u2013  August 2010  (2 years 1 month) R&D of organic chemistry and developing of automated Radioactive synthesis.  \nRadiochemistry reasarch and rutine production Senior Research Associate II Gilead Sciences February 2015  \u2013 Present (7 months) Foster City Phase III support for combo drug product. Senior Research Associate II Gilead Sciences February 2015  \u2013 Present (7 months) Foster City Phase III support for combo drug product. Analytical Chemistry Research Associate Genentech June 2012  \u2013  February 2015  (2 years 9 months) South San Francisco Phase ll support for drug product (DP) and active pharmaceutical ingredients (API) development. HPLC/ UPLC method development for late stage research projects. Ion chromatography with IC systems and with HPLC (based on HILIC and CAD detection). Dissolution / disintegration tests, content and blend uniformity. HSGC with FID and EI-MS detection. H-1/C-13 NMR. Particle size analysis and more. Analytical Chemistry Research Associate Genentech June 2012  \u2013  February 2015  (2 years 9 months) South San Francisco Phase ll support for drug product (DP) and active pharmaceutical ingredients (API) development. HPLC/ UPLC method development for late stage research projects. Ion chromatography with IC systems and with HPLC (based on HILIC and CAD detection). Dissolution / disintegration tests, content and blend uniformity. HSGC with FID and EI-MS detection. H-1/C-13 NMR. Particle size analysis and more. Radiochemistry Research Assistant Stanford University Medical Center January 2011  \u2013  June 2012  (1 year 6 months) Production of imaging probes for proliferation, angiogenesis and metabolism. \nReviewing and editing of SOP's, master batch recordes and QC forms. Radiochemistry Research Assistant Stanford University Medical Center January 2011  \u2013  June 2012  (1 year 6 months) Production of imaging probes for proliferation, angiogenesis and metabolism. \nReviewing and editing of SOP's, master batch recordes and QC forms. Organic Chemistry Hadassah medical center August 2008  \u2013  August 2010  (2 years 1 month) Independent research and development of click chemistry probe for peptide and small molecules labeling Organic Chemistry Hadassah medical center August 2008  \u2013  August 2010  (2 years 1 month) Independent research and development of click chemistry probe for peptide and small molecules labeling Radiochemistry Hadassah August 2008  \u2013  August 2010  (2 years 1 month) R&D of organic chemistry and developing of automated Radioactive synthesis.  \nRadiochemistry reasarch and rutine production Radiochemistry Hadassah August 2008  \u2013  August 2010  (2 years 1 month) R&D of organic chemistry and developing of automated Radioactive synthesis.  \nRadiochemistry reasarch and rutine production Languages Hebrew Hebrew Hebrew Skills Organic Synthesis Chemistry Organic Chemistry GMP Characterization Chromatography Cancer Spectroscopy Quality Control Clinical SOP QC RP-HPLC SFC GC-MS LC-MS NMR spectroscopy Ion Chromatography Dissolution Testing Phase 2 See 5+ \u00a0 \u00a0 See less Skills  Organic Synthesis Chemistry Organic Chemistry GMP Characterization Chromatography Cancer Spectroscopy Quality Control Clinical SOP QC RP-HPLC SFC GC-MS LC-MS NMR spectroscopy Ion Chromatography Dissolution Testing Phase 2 See 5+ \u00a0 \u00a0 See less Organic Synthesis Chemistry Organic Chemistry GMP Characterization Chromatography Cancer Spectroscopy Quality Control Clinical SOP QC RP-HPLC SFC GC-MS LC-MS NMR spectroscopy Ion Chromatography Dissolution Testing Phase 2 See 5+ \u00a0 \u00a0 See less Organic Synthesis Chemistry Organic Chemistry GMP Characterization Chromatography Cancer Spectroscopy Quality Control Clinical SOP QC RP-HPLC SFC GC-MS LC-MS NMR spectroscopy Ion Chromatography Dissolution Testing Phase 2 See 5+ \u00a0 \u00a0 See less Education Bar-Ilan University M.Sc,  Synthetic Organic Chemistry 2007  \u2013 2009 Thesis subject: Synthesis and DNA hybridization tests of chiral PNAs. \nincludes solid phase organic synthesis of PNA, usage of real time PCR, separations by gel chromatography as well as routine characterization of organic compounds Activities and Societies:\u00a0 Teaching Assistant in Organic Chemistry (2007-2008).\nlab instructor in general chemistry (both for B.Sc students) Bar-Ilan University M.Sc,  Synthetic Organic Chemistry 2007  \u2013 2009 Thesis subject: Synthesis and DNA hybridization tests of chiral PNAs. \nincludes solid phase organic synthesis of PNA, usage of real time PCR, separations by gel chromatography as well as routine characterization of organic compounds Activities and Societies:\u00a0 Teaching Assistant in Organic Chemistry (2007-2008).\nlab instructor in general chemistry (both for B.Sc students) Bar-Ilan University M.Sc,  Synthetic Organic Chemistry 2007  \u2013 2009 Thesis subject: Synthesis and DNA hybridization tests of chiral PNAs. \nincludes solid phase organic synthesis of PNA, usage of real time PCR, separations by gel chromatography as well as routine characterization of organic compounds Activities and Societies:\u00a0 Teaching Assistant in Organic Chemistry (2007-2008).\nlab instructor in general chemistry (both for B.Sc students) Bar-Ilan University M.Sc,  Synthetic Organic Chemistry 2007  \u2013 2009 Thesis subject: Synthesis and DNA hybridization tests of chiral PNAs. \nincludes solid phase organic synthesis of PNA, usage of real time PCR, separations by gel chromatography as well as routine characterization of organic compounds Activities and Societies:\u00a0 Teaching Assistant in Organic Chemistry (2007-2008).\nlab instructor in general chemistry (both for B.Sc students) "]}